about
Natural Products: Insights into Leishmaniasis Inflammatory ResponseDevelopment and Validation of a Novel Leishmania donovani Screening Cascade for High-Throughput Screening Using a Novel Axenic Assay with High Predictivity of Leishmanicidal Intracellular Activity.Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sicknessDrug resistance in eukaryotic microorganisms.Visceral Leishmaniasis in a patient with rheumatoid arthritis undergoing treatment with methotrexate: Case report and review of the literatureRegulation of Leishmania (L.) amazonensis protein expression by host T cell dependent responses: differential expression of oligopeptidase B, tryparedoxin peroxidase and HSP70 isoforms in amastigotes isolated from BALB/c and BALB/c nude mice.Cutaneous leishmaniasis: recent developments in diagnosis and managementDevelopment of an Immunochromatographic Test for Diagnosis of Visceral Leishmaniasis Based on Detection of a Circulating Antigen.Molecular Chaperones of Leishmania: Central Players in Many Stress-Related and -Unrelated Physiological Processes.The Immunology of a Healing Response in Cutaneous Leishmaniasis Treated with Localized Heat or Systemic Antimonial Therapy.Oral Efficacy of Apigenin against Cutaneous Leishmaniasis: Involvement of Reactive Oxygen Species and Autophagy as a Mechanism of Action.Efficacy and Safety of Liposomal Amphotericin B for the Treatment of Mucosal Leishmaniasis from the New World: A Retrospective StudyVisceral leishmaniasis in a patient with systemic lupus erythematosus.IL-17A promotes susceptibility during experimental visceral leishmaniasis caused by Leishmania donovaniA case of panuveitis with hypopyon due to presumed ocular leishmaniasis in a HIV patient.Effect of Topical Morphine on Cutaneous Leishmaniasis in an Animal Model: A Preliminary ReportHSP70 of Leishmania amazonensis alters resistance to different stresses and mitochondrial bioenergeticsOptimizing Immunization Strategies for the Induction of Antigen-Specific CD4 and CD8 T Cell Responses for Protection against Intracellular Parasites.Therapeutic effect of ursolic acid in experimental visceral leishmaniasisNanoparticles as multifunctional devices for the topical treatment of cutaneous leishmaniasis.Immunity to visceral leishmaniasis: implications for immunotherapy.Antimicrobial activity of oleanolic and ursolic acids: an update.Permissive and protective roles for neutrophils in leishmaniasis.Leishmania hijacking of the macrophage intracellular compartments.Host resistance to visceral leishmaniasis: prevalence and prevention.Novel Heteroaryl Selenocyanates and Diselenides as Potent Antileishmanial Agents.Antimonial drugs entrapped into phosphatidylserine liposomes: physicochemical evaluation and antileishmanial activity.Nanoliposomal Buparvaquone Immunomodulates Leishmania infantum-Infected Macrophages and Is Highly Effective in a Murine Model.Computer-Aided Drug Design Using Sesquiterpene Lactones as Sources of New Structures with Potential Activity against Infectious Neglected Diseases.Dynamic protein S-palmitoylation mediates parasite life cycle progression and diverse mechanisms of virulence.In Vitro Assessment of Plants Growing in Cuba Belonging to Solanaceae Family Against Leishmania amazonensis.Visceral Leishmaniasis in Southeastern Iran: A Narrative Review.Visceral leishmaniasis without fever in an 11-month-old infant: a rare clinical feature of Kala-azar.EVALUATION OF EXPERIMENTAL INFECTION WITH L. (L.) AMAZONENSIS IN X-LINKED IMMUNODEFICIENT MICE.Crotoxin stimulates an M1 activation profile in murine macrophages during Leishmania amazonensis infection.Comparative genomics of Tunisian Leishmania major isolates causing human cutaneous leishmaniasis with contrasting clinical severity.Visceral leishmaniasis in two patients with IL-12p40 and IL-12Rβ1 deficiencies.Transgenic T cell-specific expression of CXCR3 enhances splenic and hepatic T cell accumulation but does not affect the outcome of visceral leishmaniasis.Chronic generalized fibrotic skin lesions from disseminated leishmaniasis caused by Leishmania martiniquensis in two patients from northern Thailand infected with HIV.Leishmaniasis, lupus nephritis and immunosuppressive therapy.
P2860
Q26779924-5B18A440-7F94-430E-9A37-8983D87E8FD8Q28548536-D3B92BAE-5D25-46CF-9712-CA4A8EAEAE5FQ28817181-7068AFFE-F1DB-4664-AF58-A561C8EFC80BQ30248243-6C40FA6B-7370-41AA-AD90-479EBFF32AAAQ33806679-77A5DF6A-66D2-4DBE-A55B-858FCB3FC709Q35097514-D4473E32-2EBD-44BF-94D7-30AC7A062B04Q35187729-EF8D3203-D80F-468F-B036-91A6D5659D93Q35678524-72A14295-33B0-44B9-9749-FAF61A413581Q35808069-5991289C-515A-4ABE-90A8-CE04A9A30AE1Q35814748-7FAD2833-2D18-4EA0-9B55-88AA1CC4A1FDQ35919447-5934EAE2-CE70-4FDA-BB79-4715995CA961Q36359258-608454A8-C2E0-41D1-A8FA-DF6FC5841363Q36460404-F2C17855-1AA7-48C5-93C2-80D778B4F010Q36570892-A8274977-DB2B-4B96-A60D-E7E17716CCA1Q36944349-C188BC2D-71D8-4C44-8B3A-846E77BF7851Q37081225-12F2BAF6-4F61-4AFD-9D92-E2E1735CAEC3Q37118526-8803B0C0-2CA8-41CE-9DC7-F37E898965CEQ37239554-8FFFB3BE-6EB5-4363-8548-C0BF23065E07Q37503612-0D2EF06F-A331-4F7C-B414-7B8DB4168093Q38195310-96F6A7DE-3B6D-4FBE-A3C1-D745451AFDF0Q38243220-BD2FA139-E185-4E10-9E50-A83569D8E88EQ38385042-4E1879AE-06B5-463D-B824-7880F6A05676Q38540870-EE4B6E36-0249-4DAA-89E3-4147185E618CQ38640144-193DBEEC-C8EA-4AA1-A323-2CD558918282Q38757973-456F0B5A-620B-4DE0-A3C6-708975724496Q38891993-74B8A612-8BC0-4258-85C8-70BEB9A863D8Q38914848-B08350C5-BAD2-49AD-AABA-0E85264C0C49Q38959471-89A9CB77-D49F-4955-857E-C987F60C5182Q39065488-21E17921-A703-41C7-986D-D77E290643FDQ39146927-5570A1C3-8EF0-49D5-AB95-DC101F6AD46DQ39264754-1FB85AD2-4A7C-4B9B-BE54-56FDBACE1FE5Q39452262-7C8F26D3-A149-4A60-9333-D777DF0E93DFQ39805622-30DA219C-FFA0-4C41-9733-D1ADD3D49F7FQ40103940-8E55A5BE-2447-4FA4-8C01-7E7DD6335B9CQ40161712-84F0769F-EE81-4F71-A3DA-BE66060ACBC5Q40418320-E9ECD976-9776-4619-A111-724FE38A996BQ40440983-C8C38DCA-DFD4-47C2-B540-D2652269DEE8Q40544538-33BF4AF9-A94D-4DB8-AA57-C6248966EF79Q41139503-D007C7C1-65BD-4354-BCFA-E73E5036CA73Q41412005-DF59624A-2A99-46DE-944E-0A47ADAECB5A
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Leishmaniasis: clinical syndromes and treatment.
@en
Leishmaniasis: clinical syndromes and treatment.
@nl
type
label
Leishmaniasis: clinical syndromes and treatment.
@en
Leishmaniasis: clinical syndromes and treatment.
@nl
prefLabel
Leishmaniasis: clinical syndromes and treatment.
@en
Leishmaniasis: clinical syndromes and treatment.
@nl
P2860
P356
P1476
Leishmaniasis: clinical syndromes and treatment.
@en
P2093
A R Satoskar
B S McGwire
P2860
P356
10.1093/QJMED/HCT116
P407
P577
2013-06-05T00:00:00Z